The Cedar Project: Methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities

Drug and Alcohol Review

Volumn 30, Issue 6, 2011, Pages 645-651

  Yang, Jerome ^a   Oviedo Joekes, Eugenia ^b,c   Christian, Kukpi Wayne M ^d   Li, Kathy ^c   Louie, Mabel ^e   Schechter, Martin ^b,c   Spittal, Patricia ^b,c  

^a Pender Community Health Centre   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

^d Lakes Division of Secwepemc Nation   (Canada)

^e Carrier Sekani Family Services   (Canada)

Author keywords

Aboriginal people; Canada; Drug use; Methadone

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADOLESCENT; ADULT; AMERICAN INDIAN; ARTICLE; CANADA; ETHNOLOGY; FEMALE; HEALTH CARE DELIVERY; HUMAN; MALE; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; CANADA; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INDIANS, NORTH AMERICAN; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES;

EID: 80355123948     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2010.00258.x     Document Type: Article

References (54)

1. Statistics Canada [Internet]. Ottawa, Ontario. Aboriginal Peoples Highlight Tables, 2006 Census. Available at: (accessed December 2010).
2. BC Stats [Internet]. Victoria, British Columbia. Aboriginal Profiles. Available at: (accessed January 2010).
3. Kendall PR. Pathways to health and healing. 2nd report on the health and well-being of Aboriginal people in British Columbia. Victoria: Ministry of Healthy Living and Sport, 2009. Available at: (accessed December 2010).
4. Public Health Agency of Canada. HIV/AIDS among Aboriginal persons in Canada: a continuing concern. HIV/AIDS Epi Updates November 2007. Available at: (accessed January 2010).
5. Wardman D, Quantz D. Harm reduction services for British Columbia's First Nation population: a qualitative inquiry into opportunities and barriers for injection drug users. Harm Reduct J 2006;3:30. Available at: (accessed January 2010).
6. Canadian Aboriginal AIDS Network. Joining the circle: an Aboriginal harm reduction model. 1998. Available at: (accessed January 2010).
7. Canadian Aboriginal AIDS Network. Strengthening ties-strengthening communities. An Aboriginal strategy on HIV/AIDS in Canada for First Nations, Inuit and Métis People. 2003. Available at: (accessed December 2010).
8. Miller CL, Strathdee SA, Spittal PM, etal. Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting. Harm Reduct J 2006;3:9. Available at: (accessed January 2010).
9. Methadone Strategy Working Group. Countering the crisis: Ontario's prescription for opioid dependence. 2001. Available at: (accessed January 2010).
10. Canadian Aboriginal AIDS Network. Foundations of a good practices approach. Ottawa: Canadian Aboriginal AIDS Network, 2004. Available at: (accessed December 2010).
11. Duran B, Oetzel J, Lucero J, Jiang Y. Obstacles for rural American Indians seeking alcohol, drug, or mental health treatment. J Consult Clin Psychol 2005;73:819-29.
12. Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ 2003;168:19-24.
13. Assembly of First Nations/First Nations Information Governance Committee. Alcohol and drug use (chapter 10). In: First Nations Regional Longitudinal Health Survey (RHS). Results for adults, youth, and children living in First Nations Communities. Ottawa: RHS National Team, 2007. p. 114. Available at: (accessed December 2010).
14. Gibson DR, Flynn NM, McCarthy JJ. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 1999;13:1807-18.
15. Lollis CM, Strothers HS, Chitwood DD, McGhee M. Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior? J Behav Med 2000;23:545-57.
16. Gowing LR, Farrell M, Bornemann R, Sullivan LE, Ali RL. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2008; Accession no: CD004145. DOI: 10.1002/14651858.CD004145.pub3.
17. Gowing LR, Farrell M, Bornemann R, Sullivan LE, Ali RL. BRIEF REPORT: methadone treatment of injecting opioid users for prevention of HIV infection. J Gen Intern Med 2006;21:193-5.
18. Palepu A, Tyndall MW, Joy R, etal. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend 2006;84:188-94.
19. Newman R. Another wall that crumbled-methadone maintenance treatment in Germany. Am J Drug Alcohol Abuse 1995;21:27-35.
20. Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug Alcohol Depend 2006;(83):147-56.
21. Parker H, Kirby P. Methadone maintenance and crime reduction on Merseyside. London: Home Office Police Research Group, 1997. Crime Detection and Prevention Series Paper 72.
22. Yancovitz SR, Des Jarlais DC, Peyser NP, etal. A randomized trial of an interim methadone maintenance clinic. Am J Public Health 1991;81:1185-91.
23. Stenbacka M, Leifman A, Romelsjo A. The impact of methadone treatment on registered convictions and arrests in HIV-positive and HIV-negative men and women with one or more treatment periods. Drug Alcohol Rev 2003;22:27-34.
24. Kott A, Habel E, Nottingham W. Analysis of behavioral patterns in five cohorts of patients retained in methadone maintenance programs. Mt Sinai J Med 2001;68:46-54.
25. Lind B, Chen S, Weatherburn D, Mattick R. NSW Bureau of Crime Statistics and Research. The effectiveness of methadone maintenance treatment in controlling crime: an aggregate-level analysis. Crime Justice Stat 2004;March 2004:1-9. Available at: (accessed January 2010).
26. Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ. The impact of harm-reduction based methadone treatment on mortality among heroin users. Am J Public Health 2001;91:774-80.
27. Stenbacka M, Leifman A, Romelsjo A. The impact of methadone on consumption of inpatient care and mortality, with special reference to HIV status. Subst Use Misuse 1998;33:2819-34.
28. Millar JS. HIV, hepatitis, and injection drug use in British Columbia-pay now or pay later? Victoria: Office of the Provincial Health Officer, B.C. Ministry of Health, 1998. Available at: (accessed January 2010).
29. Burke D. Regarding methadone treatment: a review [monograph on the Internet]. New York: Committee of Methadone Program Administrators, Inc., 1997. Available at: (accessed January 2010).
30. Schilling R, Dornig K, Lungren L. Treatment of heroin dependence: effectiveness, costs, and benefits of methadone maintenance. Res Soc Work Pract 2006;16:48-56.
31. Hubbard RL, French MT. New perspectives on the benefit-cost and cost-effectiveness of drug abuse treatment. In: Cartwright WS, Kaple JM, eds. Economic costs, cost-effectiveness, financing, and community-based drug treatment. Rockville: National Institute on Drug Abuse, 1991:94-113. Research Monograph 113, DHHS Pub. No. (ADM) 91-1823. Available at: (accessed January 2010).
32. Flynn PM, Porto JV, Rounds-Bryant JL, Kristiansen PL. Costs and benefits of methadone treatment in DATOS-part 1: discharged versus continuing patients. J Mainten Addict 2003;2:129-50.
33. Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health 2000;90:1100-11.
34. Sheerin I, Green T, Sellman D, Adamson S, Deering D. Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. NZ Med J 2004;117:1190. Available at: (accessed January 2010).
35. Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend 2005;80:329-35.
36. Adilman S, Kliewer G. Pain and wasting on main and hastings: a perspective from the Vancouver Native Health Society medical clinic. BC Med J 2000;42:422-5.
37. Holly C, Shoobridge J. Investigating the impact of injecting drug use in Indigenous communities in metropolitan Adelaide. Adelaide: Aboriginal Drug and Alcohol Council (SA) Inc, 2002.
38. Canadian Institutes of Health Research [Internet]. Ottawa, Ontario. CIHR guidelines for health research involving Aboriginal people. 2007. Available at: (accessed September 2010).
39. Spittal PM, Craib KJ, Teegee M, etal. The Cedar Project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities. Int J Circumpolar Health 2007;66:226-40.
40. Callon C, Wood E, Marsh D, Li K, Montaner J, Kerr T. Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver. J Opioid Manag 2006;2:35-41.
41. Popova S, Rehm J, Fischer B. An overview of illegal opioid use and health services utilization in Canada. Public Health 2006;120:320-8.
42. The National Institute on Drug Abuse. Part B: 20 questions and answers regarding methadone maintenance treatment research. Available at: (accessed January 2010).
43. Kandall SR, Doberczak TM, Jantunen M, Stein J. The methadone-maintained pregnancy. Clin Perinatol 1999;26:173-83.
44. Mehrabadi A, Patterson K, Pearce M, etal. Gender differences in HIV and Hepatitis C related vulnerabilities among Aboriginal young people who use street drugs in two Canadian cities. Women Health 2008;48:235-60.
45. Grella CE, Joshi V. Gender differences in drug treatment careers among clients in the national Drug Abuse Treatment Outcome Study. Am J Drug Alcohol Abuse 1999;25:385-406.
46. Roy E, Haley N, Leclerc P, Boivin JF, Cedras L, Vincelette J. Risk factors for hepatitis C virus infection among street youths. CMAJ 2001;165:557-60.
47. Rounsaville BJ, Glazer W, Wilber CH, Weissman MM, Kleber HD. Short-term interpersonal psychotherapy in methadone maintained opiate addicts. Arch Gen Psychiatry 1983;40:629-36.
48. Roszell DK, Calsyn DA, Chaney EF. Alcohol use and psychopathology in opioid addicts on methadone maintenance. Am J Drug Alcohol Abuse 1986;12:269-78. Available at: (accessed January 2010).
49. Rengade CE, Kahn JP, Schwan R. Misuse of alcohol among methadone patients. Am J Addict 2009;18:162-6.
50. Anderson JF. Screening and brief intervention for hazardous alcohol use within Indigenous populations: potential solution or impossible dream? Addict Res Theory 2007;15:439-48.
51. Canadian Aboriginal AIDS Network. Joining the circle, phase II. Vancouver: Canadian Aboriginal AIDS Network, 2004.
52. MacPherson D. A framework for action. A four-pillar approach to drug problems in Vancouver. City of Vancouver. 2001. Available at: (accessed September 2010).
53. Williams N, Nasir R, Smither G, Troon S. Providing opioid substitution treatment to Indigenous heroin users within a community health service setting in Adelaide. Drug Alcohol Rev 2006;25:227-32.
54. Canadian Centre on Substance Abuse. Harm Reduction for Special Populations in Canada. Harm reduction policies and programs for persons of Aboriginal descent. Ottawa: Canadian Centre on Substance Abuse, 2007.